NEW YORK (
China Nepstar Chain Drugstore
(NPD - Get Report),
(EJ - Get Report),
China Real Estate Information Corp.
(WWIN) are four China companies scheduled to report their quarterly results Wednesday. Two of the four stocks reported quarterly results earlier in the day, while two have yet to.
China Nepstar Chain Drugstore is a retail drugstore chain in China. Earlier during the day, the company reported its results for the second quarter ended June 2010. Loss per share stood at 2 cents, while analysts expected earnings of 3 cents per share. Revenues increased 6% year-over-year to $83.35 million, below analysts' estimates of $90.30 million. On July 19,
Roth Capital Partners assigned a hold rating to the stock with price target of $4, implying a 32% upside over current levels.
E-House Holdings is a real estate services company in People's Republic of China providing primary real estate agency services, secondary real estate brokerage services, and real estate information and consulting services. The company is expected to report earnings of 13 cents per share as against 24 cents per share reported in the prior year's quarter. Revenues are forecasted to grow 5% to $66.43 million from $63.48 million.
On August 2,
(CS - Get Report) assigned an out perform rating to the stock with price target of $24, implying a 56% upside over current levels.
China Real Estate Information is a leading provider of real estate information, consulting and online services in China. During the second quarter ended June 2010, the company's earnings increased 1.6% year-over-year to $7.47 million or 5 cents per share. Analysts estimated earnings of 4 cents per share. However, revenues surged 96% to $37.40 million, while organic revenues were up 21% year-over-year.
Looking forward to the third quarter, China Real Estate Information estimates organic growth of 21-25% year-over-year. On August 2, Credit Suisse assigned an outperform rating to the stock with price target of $11, representing a 13% upside over current levels.
Winner Medical Group is engaged in the business of researching and developing, manufacturing and marketing of medical dressings and medical disposables. According to analysts polled by
, the company is expected to report earnings of 13 cents per share as against 14 cents per share reported a year earlier. Revenues are forecasted to grow 31% y-o-y to $31.90 million.
On August 10, Roth Capital Partners assigned a buy rating to the stock with price target of $10, implying a 61% upside over current levels.